Literature DB >> 17972161

The relationship between tissue Doppler imaging and seric NTproBNP levels in sinus rhythm patients: a prospective study.

Cristian Mornos1, Adina Ionac, Dragos Cozma, Dan Rusinaru, Daniela Maximov, Lucian Petrescu, Alina Lupu, Stefan-Iosif Dragulescu.   

Abstract

UNLABELLED: N-terminal pro-brain natriuretic peptide (NTproBNP) correlates with left ventricular (LV) filling pressure. The ratio between early diastolic transmitral velocity and early mitral annular diastolic velocity (E/Ea) reflects LV filling pressure in a variety of cardiac diseases. However this relationship was not validated in some categories of patients. Our aim was to evaluate the correlation between tissue Doppler velocities of the mitral annulus and NTproBNP levels in sinus rhythm patients.
METHODS: Echocardiography was performed in 111 consecutive patients simultaneously with NTproBNP measurement. E/Ea and E/(Ea x Sa) were calculated (Sa is the maximal systolic velocity of mitral annulus); the average of the velocities of septal and lateral mitral annulus was used.
RESULTS: Simple regression analysis demonstrated a significant linear correlation between E/(Ea x Sa) and NTproBNP (r = 0.71, P < 0.0001), superior to E/Ea correlation (r = 0.58, P < 0.0001). Significant but weaker correlations were found between NTproBNP and Sa, pulmonary artery systolic pressure, Ea, mitral E/A (early/late diastolic transmitral velocity), E wave, mitral E deceleration time and LV ejection fraction (LVEF). The optimal E/(Ea x Sa) cut-off for prediction of NTproBNP levels > 900 pg/ml was 1.5 (sensitivity = 81%, specificity = 70%). Among analyzed parameters, E/(Ea x Sa) was best correlated with NTproBNP levels in patients with LVEF >or= 50% (r = 0.80, P < 0.0001), with depressed LVEF (<50%) (r = 0.66, P < 0.0001), with regional wall motion abnormalities (r = 0.75, P < 0.0001), and with E/Ea 8 to 15 (r = 0.58, P < 0.0001).
CONCLUSIONS: E/(Ea x Sa) strongly correlates with NTproBNP, regardless of LVEF, and can be a simple and accurate echocardiographic index in patients in sinus rhythm, particularly in those with regional wall motion abnormalities or intermediate E/Ea.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17972161     DOI: 10.1007/s10554-007-9279-8

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  25 in total

1.  Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study.

Authors:  S R Ommen; R A Nishimura; C P Appleton; F A Miller; J K Oh; M M Redfield; A J Tajik
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

2.  Tissue Doppler velocities of mitral annulus and NT-proBNP in patients with heart failure.

Authors:  Martin Tretjak; Franc Verovnik; Davorin Benko; Mirta Kozelj
Journal:  Eur J Heart Fail       Date:  2005-06       Impact factor: 15.534

Review 3.  Recommendations for chamber quantification.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack Shanewise; Scott Solomon; Kirk T Spencer; Martin St John Sutton; William Stewart
Journal:  Eur J Echocardiogr       Date:  2006-02-02

Review 4.  Natriuretic peptides in the diagnosis and management of heart failure.

Authors:  G Michael Felker; John W Petersen; Daniel B Mark
Journal:  CMAJ       Date:  2006-09-12       Impact factor: 8.262

5.  Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.

Authors:  Daniel G Krauser; Donald M Lloyd-Jones; Claudia U Chae; Renee Cameron; Saif Anwaruddin; Aaron L Baggish; Annabel Chen; Roderick Tung; James L Januzzi
Journal:  Am Heart J       Date:  2005-04       Impact factor: 4.749

6.  A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.

Authors:  R Kazanegra; V Cheng; A Garcia; P Krishnaswamy; N Gardetto; P Clopton; A Maisel
Journal:  J Card Fail       Date:  2001-03       Impact factor: 5.712

7.  The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

Authors:  James L Januzzi; Carlos A Camargo; Saif Anwaruddin; Aaron L Baggish; Annabel A Chen; Daniel G Krauser; Roderick Tung; Renee Cameron; J Tobias Nagurney; Claudia U Chae; Donald M Lloyd-Jones; David F Brown; Stacy Foran-Melanson; Patrick M Sluss; Elizabeth Lee-Lewandrowski; Kent B Lewandrowski
Journal:  Am J Cardiol       Date:  2005-04-15       Impact factor: 2.778

8.  Impact of obesity on plasma natriuretic peptide levels.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2004-02-10       Impact factor: 29.690

Review 9.  Essential biochemistry and physiology of (NT-pro)BNP.

Authors:  Christian Hall
Journal:  Eur J Heart Fail       Date:  2004-03-15       Impact factor: 15.534

Review 10.  Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions.

Authors:  Michael A Burke; William G Cotts
Journal:  Heart Fail Rev       Date:  2007-03-08       Impact factor: 4.654

View more
  3 in total

1.  The prognostic value of a new tissue Doppler parameter in patients with heart failure.

Authors:  Cristian Mornoş; Lucian Petrescu; Adina Ionac; Dragoş Cozma
Journal:  Int J Cardiovasc Imaging       Date:  2013-09-17       Impact factor: 2.357

2.  Correlation between N-Terminal Pro-Brain Natriuretic Peptide and Doppler Echocardiographic Parameters of Left Ventricular Filling Pressure in Atrial Fibrillation.

Authors:  Woo Shin Kim; Seong-Hoon Park
Journal:  J Cardiovasc Ultrasound       Date:  2011-03-31

3.  Optimal screening of heart failure patients: tissue Doppler imaging or plasma NTpro BNP measurement?

Authors:  Leo H B Baur
Journal:  Int J Cardiovasc Imaging       Date:  2008-01-31       Impact factor: 2.357

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.